D.E. Shaw & Co’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-78,218
| Closed | -$1.06M | – | 3165 |
|
|
2025
Q1 | $1.06M | Buy |
+78,218
| New | +$1.06M | ﹤0.01% | 2147 |
|
|
2024
Q3 | – | Sell |
-29,721
| Closed | -$690K | – | 3224 |
|
|
2024
Q2 | $690K | Sell |
29,721
-86,544
| -74% | -$2.01M | ﹤0.01% | 2345 |
|
|
2024
Q1 | $2.39M | Buy |
+116,265
| New | +$2.39M | ﹤0.01% | 1666 |
|
|
2023
Q2 | – | Sell |
-44,336
| Closed | -$1.02M | – | 3150 |
|
|
2023
Q1 | $1.02M | Sell |
44,336
-90,091
| -67% | -$2.08M | ﹤0.01% | 2190 |
|
|
2022
Q4 | $3.74M | Buy |
+134,427
| New | +$3.74M | ﹤0.01% | 1636 |
|
|
2022
Q3 | – | Sell |
-86,113
| Closed | -$2.53M | – | 3956 |
|
|
2022
Q2 | $2.53M | Buy |
86,113
+79,865
| +1,278% | +$2.35M | ﹤0.01% | 2103 |
|
|
2022
Q1 | $201K | Sell |
6,248
-988
| -14% | -$31.8K | ﹤0.01% | 3625 |
|
|
2021
Q4 | $323K | Sell |
7,236
-38,177
| -84% | -$1.7M | ﹤0.01% | 3287 |
|
|
2021
Q3 | $2.29M | Sell |
45,413
-38,172
| -46% | -$1.93M | ﹤0.01% | 2009 |
|
|
2021
Q2 | $6.56M | Sell |
83,585
-122,577
| -59% | -$9.62M | 0.01% | 1293 |
|
|
2021
Q1 | $11.8M | Buy |
206,162
+126,802
| +160% | +$7.24M | 0.01% | 928 |
|
|
2020
Q4 | $6.65M | Sell |
79,360
-65,658
| -45% | -$5.5M | 0.01% | 1172 |
|
|
2020
Q3 | $5.2M | Buy |
+145,018
| New | +$5.2M | 0.01% | 1166 |
|
|
2019
Q3 | – | Sell |
-102,274
| Closed | -$2.12M | – | 2596 |
|
|
2019
Q2 | $2.12M | Buy |
+102,274
| New | +$2.12M | ﹤0.01% | 1592 |
|